Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NUGT and JNUG are both rocking!
I hope so for your all's sake.
Real PR?
All they need is real business and they are missing out on the best situation to show their stuff.
Lots of insider buying since December.
Of course they are can you blame them?
But look at all the other newcomers listed.
No mention of Careclix.
This is the time for Careclix to get noticed and it's failing.
Errr, okay.
Read and do your own DD.
Today.
Open it.
Teladoc: An Expensive Stock Worth Buying Today https://seekingalpha.com/article/4330316?source=ansh $TDOC
Makes one wonder doesn't it.
I bailed after losing my ass and went into $TDOC.
Here is an interesting article with no mention of Careclix.
The growth of this industry has attracted many companies. A good example of this is Zoom Video (ZM), the company best-known for video conferences. The company has recently launched its telehealth services that could compete with Teladoc in the future. Other companies offering the same service have received a substantial amount of money from venture capital. Doctor on Demand has raised more than $160 million, HealthTap has raised more than $88 million, while Ro has raised more than $176 million. Other well-funded companies in the industry are 98point6, The Pill Club, Maven Clinic, and Nurx, among others. The chart below shows Teladoc’s market share in 2017.
Others not negatively affected by Corona virus are $TDOC, $ZM and $SAFE.
Glad I was able to add more MSFT.
Exactly.
Yeah, it sure crashed hard
??
Here we go again,,, *sigh*
Nevermind,, lol!
I bought in at the drop.
I'm rooting for good Phase 3 news this quarter on their migraine drug.
Okay, what happened today?!
I just joined the club!
Thanks for the link.
CRISP talk brought me here.
Any guess on when Phase 3 results will be announced?
Their anxiety drug failed today.
Might be a good time to buy in if you believe their potential blockbuster Migraine drug passes Phase 3 this 1st quarter.
Even thou they beat estimates by a penny.
I had forgotten about Trebeck.
I hope preclinical data gets some attention.
If not, then we have a long wait.
Just shit up a couple percent
Tyme Technologies (NASDAQ:TYME): Q3 GAAP EPS of -$0.06 beats by $0.01.
Do I wait for the next catalyst which is later in the year, or sell and but an $apple, or $microsoft and get over 50% gain in that time?
Check out Seeking Alpha, January 27, article.
Lots of insider buying and Fast Track status.
Good time to buy into BX.
SAFE has had a lot of Insider buying and been moving up.
Not now.
I'll be back thou.
I'm in $BX and $SAFE in its place.
Hope it shows up positive tomorrow.
That is a robust pipeline.
I think so,, might take awhile but we should hear that slam dunk with patience
Now we wait,,, might be a year long wait, but if it keeps inching up every week, then I see no reason to sell, then buy back later.
But we have a long ways to go to the results.
But as long as it's gaining like a decent SP 500 stock until that time, then all's well.
And mild news of dosing
Iv been four out of six on his recommendations.
As long as one spreads out their specs, one should come out ahead on his recommendations.
WOOOHOOO!!!
Up 15%
Right now at the open would be good.
Very bizarre
Thinking December of 2020,0, yes, one year away.
clinicaltrials.gov